133 related articles for article (PubMed ID: 15966900)
21. The glucocorticoid receptor interacting protein 1 (GRIP1) localizes in discrete nuclear foci that associate with ND10 bodies and are enriched in components of the 26S proteasome.
Baumann CT; Ma H; Wolford R; Reyes JC; Maruvada P; Lim C; Yen PM; Stallcup MR; Hager GL
Mol Endocrinol; 2001 Apr; 15(4):485-500. PubMed ID: 11266502
[TBL] [Abstract][Full Text] [Related]
22. A small amphipathic alpha-helical region is required for transcriptional activities and proteasome-dependent turnover of the tyrosine-phosphorylated Stat5.
Wang D; Moriggl R; Stravopodis D; Carpino N; Marine JC; Teglund S; Feng J; Ihle JN
EMBO J; 2000 Feb; 19(3):392-9. PubMed ID: 10654938
[TBL] [Abstract][Full Text] [Related]
23. Involvement of proteasomes in gene induction by interferon and double-stranded RNA.
Li XL; Hassel BA
Cytokine; 2001 Jun; 14(5):247-52. PubMed ID: 11444904
[TBL] [Abstract][Full Text] [Related]
24. In vivo degradation of N-myc in neuroblastoma cells is mediated by the 26S proteasome.
Bonvini P; Nguyen P; Trepel J; Neckers LM
Oncogene; 1998 Mar; 16(9):1131-9. PubMed ID: 9528855
[TBL] [Abstract][Full Text] [Related]
25. The ubiquitin-proteasome system and cellular proliferation and regulation in osteoblastic cells.
Murray EJ; Bentley GV; Grisanti MS; Murray SS
Exp Cell Res; 1998 Aug; 242(2):460-9. PubMed ID: 9683533
[TBL] [Abstract][Full Text] [Related]
26. Oncogenic activation of c-Myb by carboxyl-terminal truncation leads to decreased proteolysis by the ubiquitin-26S proteasome pathway.
Bies J; Wolff L
Oncogene; 1997 Jan; 14(2):203-12. PubMed ID: 9010222
[TBL] [Abstract][Full Text] [Related]
27. Mouse homologue of yeast Prp19 interacts with mouse SUG1, the regulatory subunit of 26S proteasome.
Sihn CR; Cho SY; Lee JH; Lee TR; Kim SH
Biochem Biophys Res Commun; 2007 Apr; 356(1):175-80. PubMed ID: 17349974
[TBL] [Abstract][Full Text] [Related]
28. Proteasome inhibitors up-regulate haem oxygenase-1 gene expression: requirement of p38 MAPK (mitogen-activated protein kinase) activation but not of NF-kappaB (nuclear factor kappaB) inhibition.
Wu WT; Chi KH; Ho FM; Tsao WC; Lin WW
Biochem J; 2004 May; 379(Pt 3):587-93. PubMed ID: 14731112
[TBL] [Abstract][Full Text] [Related]
29. Phosphorylated alpha-synuclein at Ser-129 is targeted to the proteasome pathway in a ubiquitin-independent manner.
Machiya Y; Hara S; Arawaka S; Fukushima S; Sato H; Sakamoto M; Koyama S; Kato T
J Biol Chem; 2010 Dec; 285(52):40732-44. PubMed ID: 20959456
[TBL] [Abstract][Full Text] [Related]
30. Both Rb and E7 are regulated by the ubiquitin proteasome pathway in HPV-containing cervical tumor cells.
Wang J; Sampath A; Raychaudhuri P; Bagchi S
Oncogene; 2001 Aug; 20(34):4740-9. PubMed ID: 11498796
[TBL] [Abstract][Full Text] [Related]
31. In vivo ubiquitination and proteasome-mediated degradation of p53(1).
Maki CG; Huibregtse JM; Howley PM
Cancer Res; 1996 Jun; 56(11):2649-54. PubMed ID: 8653711
[TBL] [Abstract][Full Text] [Related]
32. Centrin/Cdc31 is a novel regulator of protein degradation.
Chen L; Madura K
Mol Cell Biol; 2008 Mar; 28(5):1829-40. PubMed ID: 18160718
[TBL] [Abstract][Full Text] [Related]
33. Influence of p53 and p21Waf1 expression on G2/M phase arrest of colorectal carcinoma HCT116 cells to proteasome inhibitors.
Kim OH; Lim JH; Woo KJ; Kim YH; Jin IN; Han ST; Park JW; Kwon TK
Int J Oncol; 2004 Apr; 24(4):935-41. PubMed ID: 15010833
[TBL] [Abstract][Full Text] [Related]
34. Geldanamycin-stimulated destabilization of mutated p53 is mediated by the proteasome in vivo.
Whitesell L; Sutphin P; An WG; Schulte T; Blagosklonny MV; Neckers L
Oncogene; 1997 Jun; 14(23):2809-16. PubMed ID: 9190897
[TBL] [Abstract][Full Text] [Related]
35. [Effect of EGF on ubiquitination and proteasome-dependent degradation of phospholipase C gamma1 in A431 cells].
Evdonin AL; Tsupkina NV; Nikol'skiĭ NN; Medvedeva ND
Tsitologiia; 2003; 45(10):1013-8. PubMed ID: 14989173
[TBL] [Abstract][Full Text] [Related]
36. Apolipoprotein E in macrophages and hepatocytes is eegraded via the proteasomal pathway.
Wenner C; Lorkowski S; Engel T; Cullen P
Biochem Biophys Res Commun; 2001 Mar; 282(2):608-14. PubMed ID: 11401504
[TBL] [Abstract][Full Text] [Related]
37. Ubiquitin-proteasome pathway mediates degradation of APH-1.
He G; Qing H; Cai F; Kwok C; Xu H; Yu G; Bernstein A; Song W
J Neurochem; 2006 Dec; 99(5):1403-12. PubMed ID: 17059559
[TBL] [Abstract][Full Text] [Related]
38. Regulation and deregulation of E2F1 in postmitotic neurons differentiated from embryonal carcinoma P19 cells.
Azuma-Hara M; Taniura H; Uetsuki T; Niinobe M; Yoshikawa K
Exp Cell Res; 1999 Sep; 251(2):442-51. PubMed ID: 10471329
[TBL] [Abstract][Full Text] [Related]
39. The 26S proteasome system degrades the ERM transcription factor and regulates its transcription-enhancing activity.
Baert JL; Beaudoin C; Monte D; Degerny C; Mauen S; de Launoit Y
Oncogene; 2007 Jan; 26(3):415-24. PubMed ID: 16832340
[TBL] [Abstract][Full Text] [Related]
40. Rad23 links DNA repair to the ubiquitin/proteasome pathway.
Schauber C; Chen L; Tongaonkar P; Vega I; Lambertson D; Potts W; Madura K
Nature; 1998 Feb; 391(6668):715-8. PubMed ID: 9490418
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
